Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 499 du 17 septembre 2021
Lutte contre les cancers
Qualité de vie, soins de support (1)
A partir d'une revue de la littérature publiée jusqu'en novembre 2019 (26 études), cette méta-analyse évalue la qualité de vie des patients atteints d'un cancer traité par inhibiteurs de point de contrôle
Meta-Analysis of Quality of Life in Cancer Patients Treated with Immune Checkpoint Inhibitors
A partir d'une revue de la littérature publiée jusqu'en novembre 2019 (26 études), cette méta-analyse évalue la qualité de vie des patients atteints d'un cancer traité par inhibiteurs de point de contrôle
Meta-Analysis of Quality of Life in Cancer Patients Treated with Immune Checkpoint Inhibitors
Gonzalez, Brian D ; Eisel, Sarah L ; Bowles, Kristina E ; Hoogland, Aasha I ; James, Brian W ; Small, Brent J ; Sharpe, Susan ; Hyland, Kelly A ; Bulls, Hailey W ; Christy, Shannon M ; Mansfield, Jori ; Nelson, Ashley M ; Alla, Raviteja ; Maharaj, Kelly ; Kennedy, Brittany ; Lafranchise, Elizabeth ; Williams, Noelle L ; Jennewein, Sarah ; Oswald, Laura B ; Postow, Michael A ; Dicker, Adam P ; Jim, Heather S L
Trials of immune checkpoint inhibitors (ICIs) have published patient-reported quality of life (QOL), but the size and heterogeneity of this literature can make patient education difficult. This meta-analysis aimed to describe change in QOL and symptomatology in patients receiving ICIs for cancer.Following PRISMA guidelines, databases were searched through November 2019 for articles or abstracts of prospective, original studies reporting longitudinal QOL in adult cancer patients treated with [...]
Observation (6)
A partir d'une revue systématique de la littérature publiée entre janvier 2010 et avril 2021 (29 articles), cette étude évalue l'intérêt des services de télémédecine pour les soins post-traitement de patients ayant survécu à un cancer, puis identifie les facteurs facilitant et entravant l'utilisation de ces services
The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews
A partir d'une revue systématique de la littérature publiée entre janvier 2010 et avril 2021 (29 articles), cette étude évalue l'intérêt des services de télémédecine pour les soins post-traitement de patients ayant survécu à un cancer, puis identifie les facteurs facilitant et entravant l'utilisation de ces services
The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews
Chan, R. J. ; Crichton, M. ; Crawford-Williams, F. ; Agbejule, O. A. ; Yu, K. ; Hart, N. H. ; de Abreu Alves, F. ; Ashbury, F. D. ; Eng, L. ; Fitch, M. ; Jain, H. ; Jefford, M. ; Klemanski, D. ; Koczwara, B. ; Loh, K. ; Prasad, M. ; Rugo, H. ; Soto-Perez-de-Celis, E. ; van den Hurk, C. ; Chan, A.
Background: Telemedicine services have been increasingly used to facilitate post-treatment cancer survivorship care, including improving access; monitoring health status, health behaviors, and symptom management; enhancing information exchange; and mitigating the costs of care delivery, especially since the COVID-19 pandemic. To inform guidance for the use of telemedicine in the post-COVID era, the aim of this overview of systematic reviews was to evaluate the efficacy of, and survivor [...]
Mené aux Etats-Unis entre 2016 et 2020 sur 672 patients présentant une tumeur solide métastatique (âge médian : 69,3 ans ; 54 % de femmes), cet essai randomisé évalue l'efficacité, du point de vue de la qualité de vie jusqu'à 3 mois, d'une intervention de soins palliatifs primaires dispensée par des infirmières en oncologie
Effect of an Oncology Nurse–Led Primary Palliative Care Intervention on Patients With Advanced Cancer: The CONNECT Cluster Randomized Clinical Trial
Mené aux Etats-Unis entre 2016 et 2020 sur 672 patients présentant une tumeur solide métastatique (âge médian : 69,3 ans ; 54 % de femmes), cet essai randomisé évalue l'efficacité, du point de vue de la qualité de vie jusqu'à 3 mois, d'une intervention de soins palliatifs primaires dispensée par des infirmières en oncologie
Effect of an Oncology Nurse–Led Primary Palliative Care Intervention on Patients With Advanced Cancer: The CONNECT Cluster Randomized Clinical Trial
Schenker, Yael ; Althouse, Andrew D. ; Rosenzweig, Margaret ; White, Douglas B. ; Chu, Edward ; Smith, Kenneth J. ; Resick, Judith M. ; Belin, Shane ; Park, Seo Young ; Smith, Thomas J. ; Bakitas, Marie A. ; Arnold, Robert M.
Guidelines recommend early specialty palliative care for all patients with advanced cancer, but most patients lack access to such services.To assess the effect of CONNECT (Care Management by Oncology Nurses to Address Supportive Care Needs), a primary palliative care intervention delivered by oncology nurses, on patient outcomes.This cluster randomized clinical trial of the CONNECT intervention vs standard care was conducted from July 25, 2016, to October 6, 2020. Participants were adult [...]
Mené sur 864 patients atteints d'un cancer et présentant des symptômes importants (troubles du sommeil, douleur, anxiété, détresse émotionnelle, fatigue, limitations physiques), cet essai randomisé évalue l'intérêt des patients pour une consultation téléphonique menée par une infirmière
Receptivity to a Nurse-Led Symptom Management Intervention Amongst Highly Symptomatic Patients with Cancer
Mené sur 864 patients atteints d'un cancer et présentant des symptômes importants (troubles du sommeil, douleur, anxiété, détresse émotionnelle, fatigue, limitations physiques), cet essai randomisé évalue l'intérêt des patients pour une consultation téléphonique menée par une infirmière
Receptivity to a Nurse-Led Symptom Management Intervention Amongst Highly Symptomatic Patients with Cancer
Wintheiser, Grant A ; Ruddy, Kathryn J ; Herrin, Jeph ; Rahman, Parvez A ; Pachman, Deirdre R ; Leppin, Aaron L ; Rutten, Lila J Finney ; Lee, Minji K ; Griffin, Joan M ; Tofthagen, Cindy ; Chlan, Linda L ; Ridgeway, Jennifer L ; Mitchell, Sandra A ; Cheville, Andrea L
The symptom burden associated with cancer and its treatment can negatively impact patients’ quality of life and survival. Symptom-focused collaborative care model (CCM) interventions can improve outcomes, but only if patients engage with them. We assessed the receptivity of severely symptomatic oncology patients to a remote nurse-led CCM intervention.In a pragmatic, cluster-randomized, stepped wedge trial conducted as part of the NCI IMPACT Consortium (E2C2, NCT03892967), patients receiving [...]
Menée au Royaume-Uni à partir de données portant sur 3 739 patients atteints d'un cancer du poumon non à petites cellules diagnostiqué sur la période 2007-2017, cette étude analyse les caractéristiques des patients au moment du diagnostic, les schémas thérapeutiques et la survie globale
Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database...
Menée au Royaume-Uni à partir de données portant sur 3 739 patients atteints d'un cancer du poumon non à petites cellules diagnostiqué sur la période 2007-2017, cette étude analyse les caractéristiques des patients au moment du diagnostic, les schémas thérapeutiques et la survie globale
Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative
Snee, Michael ; Cheeseman, Sue ; Thompson, Matthew ; Riaz, Majid ; Sopwith, Will ; Lacoin, Laure ; Chaib, Carlos ; Daumont, Melinda J ; Penrod, John R ; Hall, Geoff
Objectives: To report characteristics, treatment and overall survival (OS) trends, by stage and pathology, of patients diagnosed with non-small cell lung cancer (NSCLC) at Leeds Teaching Hospital NHS Trust in 2007–2018. Design: Retrospective cohort study based on electronic medical records. Setting: Large NHS university hospital in Leeds. Participants: 3739 adult patients diagnosed with incident NSCLC from January 2007 to August 2017, followed up until March 2018. Main outcome measures: Patient [...]
Menée à partir de données des registres américains des cancers, cette étude analyse l'évolution de l'incidence du cancer du sein ER- entre 1992 et 2016, en fonction de l'origine ethnique et par groupe d'âges
Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region
Menée à partir de données des registres américains des cancers, cette étude analyse l'évolution de l'incidence du cancer du sein ER- entre 1992 et 2016, en fonction de l'origine ethnique et par groupe d'âges
Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region
Lynn, Brittny C Davis ; Chernyavskiy, Pavel ; Gierach, Gretchen L ; Rosenberg, Philip S
Incidence of estrogen receptor (ER)-negative breast cancer, an aggressive subtype, is highest in United States (US) African American women and in southern residents but has decreased overall since 1992. We assessed whether ER-negative breast cancer is decreasing in all age groups and cancer registries among non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic White (HW) women.We analyzed 17 Surveillance, Epidemiology, and End-Results Program registries (twelve for 1992-2016; five [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services
Abou-Foul, A. K. ; Ross, E. ; Abou-Foul, M. ; George, A. P.
Objective. Patients with coronavirus disease vaccine associated lymphadenopathy are increasingly being referred to healthcare services. This work is the first to report on the incidence, clinical course and imaging features of coronavirus disease vaccine associated cervical lymphadenopathy, with special emphasis on the implications for head and neck cancer services. Methods. This was a retrospective cohort study of all patients referred to our head and neck cancer clinics between 16 December [...]
Delay in Cancer Diagnosis During the Era of the Coronavirus Disease 2019 Pandemic: Learning lessons
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Delay in Cancer Diagnosis During the Era of the Coronavirus Disease 2019 Pandemic: Learning lessons
Al-Azri, M. H.
Cancer is one of the leading causes of mortality worldwide and was responsible for an estimated 9.6 million deaths in 2018, with the majority (70%) occurring in low- and middle-income countries (LMICs).1 Furthermore, cancer survival tends to be poor in LMICs, most likely due to delays in cancer diagnosis, limited access to resources and a lack of national cancer screening programmes.2 As such, the number of cancer-related deaths can be reduced if patients are diagnosed and treated early.1 Delay [...]
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies
Arrieta, Oscar ; Lara-Mejía, Luis ; Bautista-González, Elysse ; Heredia, David ; Turcott, Jenny G. ; Barrón, Feliciano ; Ramos-Ramírez, Maritza ; Cabrera-Miranda, Luis ; Salinas Padilla, Miguel Ángel ; Aguerrebere, Mercedes ; Cardona, Andrés F. ; Rolfo, Christian ; Arroyo-Hernández, Marisol ; Soto-Perez-de-Celis, Enrique ; Báez-Saldaña, Renata
Background: Accumulated evidence indicates that patients with lung cancer are a vulnerable population throughout the pandemic. Limited information is available in Latin America regarding the impact of the pandemic on medical care. The goal of this study was to describe the clinical and social effect of COVID-19 on patients with thoracic cancer and to ascertain outcomes in those with a confirmed diagnosis. Materials and Methods: This cohort study included patients with thoracic neoplasms within [...]
COVID-19 vaccination for children with cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 vaccination for children with cancer
Kotecha, R. S.
There has been a rapid global response in vaccine development since declaration of the COVID-19 pandemic in March 2020. Data are beginning to emerge establishing the safety, tolerability, immunogenicity and efficacy of COVID-19 vaccines in children and adolescents.1, 2 While children and adolescents infected with SARS-CoV-2 suffer from milder illness than adults, those with underlying health co-morbidities, including cancer, can suffer from severe disease.3, 4 Minimizing risk of exposure [...]
Antibody Response to Covid-19 mRNA Vaccine (Comirnaty), in Myeloma Patients Treated with High-dose Melphalan and/or Immunotherapy
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Antibody Response to Covid-19 mRNA Vaccine (Comirnaty), in Myeloma Patients Treated with High-dose Melphalan and/or Immunotherapy
Lockmer, S. ; Uttervall, K. ; Kashif, M. ; Svärd, C. ; Malmsten, K. ; Fletcher-Torres, E. ; Alici, E. ; Lund, J. ; Nahi, H.
Covid-19 infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) was first reported in December 2019 in Wuhan, China, and has since become a global pandemic. Symptoms range from none (subclinical infections) to acute respiratory failure including acute respiratory distress syndrome (ARDS). Risk factors for a severe course of disease include high age, male gender and comorbidities such as cardiovascular disease, diabetes, chronic obstructive pulmonary disease (COPD) [...]
B-cell haematological malignancies and SARS-CoV-2 infection: Could immunological interventions influence the outcome?
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
B-cell haematological malignancies and SARS-CoV-2 infection: Could immunological interventions influence the outcome?
Ochoa-Grullón, J. ; Peña Cortijo, A. ; Guevara-Hoyer, K. ; Jiménez García, C. ; de la Fuente, E. ; de la Peña, A. R. ; Fernández-Arquero, M. ; González Fernández, A. ; Sánchez-Ramón, S.
B cell haematological malignancies (HMs) have been described as the worst cancer type for concomitant COVID-19 in terms of mortality, with rates up to 65%. This risk factor for COVID-19 cannot only be explained by comorbidities and advanced age of patients, but aggravated by secondary immunodeficiency (SID). We aimed at evaluating the impact of COVID-19 on 86 HM patients with concomitant SID from a single centre. Only 14 HM patients of 86 (16.28%) patients suffered COVID-19, with mortality rate [...]
Comparison of Colorectal Cancer Surgery Services During COVID-19 First Wave With Pre-COVID Time
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Comparison of Colorectal Cancer Surgery Services During COVID-19 First Wave With Pre-COVID Time
Rashid, M. U. ; Raza, S. S. ; Thomas, P. ; Vakis, S.
Introduction: The first confirmed case of COVID-19 in the United Kingdom (UK) was reported on 29 January 2020. The country saw the peak of infection between March and May of 2020. The result was a change in the practice of how we treat most surgical conditions including cancer. We continued providing service to our colorectal cancer patients at a District General Hospital. The aim of this study was to compare our provision of colorectal cancer service during the peak of the pandemic to that of [...]
The Impact of COVID-19 on Patients With Cancer: A National Study of Patient Experiences
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The Impact of COVID-19 on Patients With Cancer: A National Study of Patient Experiences
Rodriguez, G. M. ; Ferguson, J. M. ; Kurian, A. ; Bondy, M. ; Patel, M. I.
OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic abruptly disrupted cancer care. The impact of these disruptions on patient experiences remain relatively understudied. The objective of this study was to assess patients' perspectives regarding the impact of COVID-19 on their experiences, including their cancer care, emotional and mental health, and social determinants of health, and to evaluate whether these outcomes differed by cancer stage. MATERIALS AND METHODS: We conducted a [...]
